<DOC>
	<DOCNO>NCT00944879</DOCNO>
	<brief_summary>This study use license HPV vaccine , Gardasil , surrogate HIV vaccine , order explore ethico-legal , psycho-social logistical challenge involve run HIV vaccine trial adolescent .</brief_summary>
	<brief_title>Preparing Adolescent HIV Vaccine Trials South Africa :</brief_title>
	<detailed_description>This study use license HPV vaccine , alternative STI vaccine , proxy HIV vaccine thereby identify potential challenge inclusion adolescent HIV prevention trial . The study allow site capacity building term recruit retain HIV-negative high-risk adolescent cohort , assess acceptability STI vaccine adolescent parent guardian . Correlates vaccine uptake , refusal , retention attrition determine . In addition , study document incidence HIV , sexually transmit infection ( STI 's ) pregnancy circumcision age group . Different method assess understanding adolescent test , ensure inform consent achieve . Experiences privacy confidentiality issue adolescent research explore . Finally , psycho-social correlate sexual risk protective behaviour examine . The study design longitudinal cohort study self-selected intervention control group . Adolescents parent recruit community outreach invite attend Vaccine Discussion Group ( VDG ) learn HPV vaccine . Parental/ legal guardian consent adolescent assent obtain prior screen . After screen ensure volunteer meet inclusion criterion , 1400 participant enrol across seven site . At point , decide whether want receive HPV vaccine . Those receive three dos , 0 , 2 6 month . All participant undergo HIV pregnancy test , receive risk reduction counsel complete questionnaire 0 , 2 , 6 9 month . Recruitment retention monitor data describe collect throughout course study .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Youth age 1217 year For 1215 year old sexual risk criterion For 1617 year old ( age lawful consent sex South Africa ) : sexually active ( ever sexual intercourse ) Willing participate HIV test counsel Willing able assent study Parent legal guardian willing provide write consent HIVnegative serostatus screen enrolment Females must negative pregnancy test screening/enrolment Females must breastfeed Additional inclusion criterion accept HPV vaccination : No HPV immunization Females agree avoid pregnancy end study take contraceptive throughout study ( access provide ) Exclusion criterion accept HPV vaccination : Presence serious illness require treatment systemic medication , exclude short course oral steroid inhale steroid treatment asthma Contraindication vaccination , bleed disorder Previous allergic reaction vaccine constituent vaccine ( yeast , thimerosal aluminum ) Current immunomodulator therapy Receipt immunosuppressor therapy ( 10mg/day prednisone equivalent &gt; 1 week ) 6 month precede enrollment date Receipt vaccine within two week precede enrollment date</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>HIV</keyword>
	<keyword>vaccine</keyword>
	<keyword>prevention</keyword>
	<keyword>HPV</keyword>
	<keyword>adolescent</keyword>
</DOC>